Can we improve outcomes by integrating molecular, pathological, and clinical data to match patients with the best therapies?
Enhance the outcomes for lung cancer patients through integrative data-driven approaches that deliver precise diagnosis and personalized treatment.
Build a learning health system that delivers a comprehensive clinical and molecular understanding of our lung cancer patients to improve their pathways to diagnosis, enable guideline-driven personalized care, and increase access to translational research.
Lung Cancer Research and Precision Medicine
Questions we're asking that inform us on how to best care for patients include:
Novel Predictive Biomarkers
Can we discover novel clinical and biological predictors of response to therapies to tailor treatment?
Adaptive Treatment Strategies
Can we identify subsets of patients where new therapeutic strategies, beyond existing guidelines, are needed?
Patient Care for Lung Cancer
Our comprehensive Lung Cancer Program includes multi-disciplinary experts at multiple clinical sites of our National Cancer Institute-designated Comprehensive Cancer Center.
Our Lung Cancer Program integrates collaborative research through the Bloomberg Kimmel Institute for Cancer Immunotherapy, the Cancer Immunology Program, and the Cancer Genetics and Epigenetics Program. Through these collaborations, we pursue translational research to improve our understanding of the molecular determinants of lung cancer therapy response and resistance.
Multidisciplinary Disease Management Team and Collaborators
Josephine Feliciano, M.D.
Associate Professor, Upper Aerodigestive Department
Russell Hales, M.D.
Director, Thoracic Oncology Multidisciplinary Program
Assistant Professor, Radiation Oncology and Molecular Radiation Sciences
Richard Battafarano, M.D.
Regional Director of General Thoracic Surgery
Associate Professor of Surgery
Lonny Yarmus, D.O.
Clinical Director, Division of Pulmonary and Critical Care Medicine
Associate Professor of Medicine
Khinh Ranh Voong, M.D., M.P.H.
Assistant Professor of Radiation Oncology and Molecular Radiation Sciences
Stephen Broderick, M.D.
Associate Director, Johns Hopkins Cardiothoracic Residency Program
Assistant Professor of Surgery